AstraZeneca and RQ Biotechnology Sign License Agreement for Monoclonal Antibodies May 23, 2022 Auto Bot News 0 AstraZeneca has signed a license agreement with RQ Biotechnology for monoclonal antibodies to treat COVID-19.
